Navigation Links
Scripps Research Institute's Richard A. Lerner Wins Prince of Asturias Award for Scientific and Technical Research
Date:5/31/2012

ards will be presented in the autumn in Oviedo at a grand ceremony chaired by H.R.H. the Prince of Asturias. For more information on the awards, see the foundation website at http://www.fpa.es/en/ .

Richard A. Lerner
Richard Alan Lerner (Chicago, USA, 1938) studied medicine at Northwestern University and Stanford, earning his MD at the latter in 1964. Following internship at the Palo Alto Stanford Hospital in 1965, he began his career in research and teaching in the Department of Experimental Pathology at The Scripps Research Institute in La Jolla (California), an institution that he led from 1986 to 2012. He is currently the Lita Annenberg Hazen Professor of Immunochemistry in the Department of Molecular Biology and a member of the Skaggs Institute for Chemical Biology at Scripps Research.

Lerner was the architect of the most important advance since the discovery of monoclonal antibodies a quarter century ago: the conception, design and creation of combinatorial antibody libraries, currently the most widely used of all libraries in the field of biochemistry and which enabled a broadening of the scope of action of the immune system. Lerner set the stage in an article published in Science in 1989 and all the advances produced in the change in combinatorial libraries derived directly or indirectly from this article. Furthermore, in 1991, Lerner identified the essence of the production of antibodies without immunization and his method has remained the most efficient way to produce fully human antibodies. Moreover, Lerner has been a pioneer in the development of what are known as catalytic antibodies, a strategy to accelerate and catalyse chemical reactions for which traditional methods are not efficient.

Author of more than 400 scientific papers, Lerner holds honorary degrees from seven universities in Europe and America. Among other awards, he has received the Wolf Prize in Chemistry (Israel,
'/>"/>

SOURCE The Scripps Research Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
2. Scripps Research Institute Scientists Develop Antidote for Cocaine Overdose
3. New Lupus Drug Results From Scripps Research Technology
4. The Scripps Research Institute Names Michael A. Marletta as President
5. Quest Diagnostics Brings Genetic Testing for Plavix(R) Response to Coronary Stent Patients at Scripps Health
6. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
7. Surgical Equipment Market (Surgical Sutures, Surgical Hand Instruments and Electrosurgical Devices) Estimated to Reach USD 7.5 Billion Globally in 2017: Transparency Market Research
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin to Treat Patients with Type 2 Diabetes
9. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
10. The Largest Private Funder Of Melanoma Research Receives Vital Support From Activist Jeffrey Epstein
11. Catheters (Cardiovascular, Specialty, Urological, Neurovascular, and Intravenous) Market Will Reach USD 33.3 Billion Globally in 2017: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015  goBalto, Inc., ... solutions, announced today unprecedented growth in serving pharmaceutical, ... intense pressure to speed clinical trials and restrain ... and paper-based methods have stalled these efforts," said ... status of clinical trials has encouraged Industry leaders, ...
(Date:7/1/2015)... , July 1, 2015 Prismic Pharmaceuticals, Inc., ... FDA-regulated medical foods, today announced the election of ... to its Board of Directors. Commenting ... Peter Moriarty , Chairman and CEO of Prismic, ... and Martin Simonetti have accepted our invitation ...
(Date:7/1/2015)... 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ... and commercialization of proprietary compounded drug formulations, today ... stock market closing bell on Thursday, July 2, ... its Go Dropless™ campaign since its launch in ... performed annually in the U.S. and more than ...
Breaking Medicine Technology:goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... N.Y., March 21, 2012  Regeneron Pharmaceuticals, Inc. (NASDAQ: ... of the Phase 1 clinical program with their ... fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type ... 22, 2012 issue of the New England ...
... March 21, 2012  Particle Sciences, Inc., a leading pharmaceutical ... Therapeutics, a specialty pharmaceutical company, a new topical dermatology ... Mitchnick, CEO of Particle Sciences, said, "There are multiple ... is in the delivery of these agents via a ...
Cached Medicine Technology:Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody 2Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody 3Regeneron Announces Data Publication and Presentations with Potential First-in-Class Lipid-Lowering PCSK9 Antibody 4
(Date:7/1/2015)... ... July 01, 2015 , ... Sir Fazle Hasan Abed, BRAC’s founder and ... Sir Fazle has been recognised for his outstanding contribution to enhancing the world's production ... President of the World Food Prize Foundation, announced this year’s winner at a ceremony ...
(Date:7/1/2015)... ... July 01, 2015 , ... For decades, researchers in the ... remain constant in the brain, never changing after development in the womb. Now, researchers ... steadily replaced in brain cells throughout life – a process which helps to switch ...
(Date:7/1/2015)... NY (PRWEB) , ... July 01, 2015 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – today announced that they will welcome four new members to their industry ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... technology and services, today announced that its fifth annual Smile for a Lifetime ... $80,000 for the non-profit organization. In addition to supporting S4L in its mission ...
(Date:7/1/2015)... ... July 01, 2015 , ... DIC Corporation today ... Linablue®, Spirulina-derived natural blue food coloring. Construction of the plant, which is located ... production base, began in May 2014. After commissioning, commercial production is expected to ...
Breaking Medicine News(10 mins):Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3
... 2010)The John Theurer Cancer Center at Hackensack University Medical ... has recognized Joseph Hanley, Ph.D., Director, Medical Physics, the ... excellence in patient safety. The team was presented ... maintaining Intensity-Modulated Radiation Therapy (IMRT) quality assurance. ...
... Mich. Prostate cancer has become more common in younger ... new study from researchers at the University of Michigan Comprehensive ... could help detect this early onset prostate cancer. Researchers ... role in predicting the risk of prostate cancer in younger ...
... published in the American Journal of Public Health ... sub-Saharan Africa. The study analyzed data from 44 sub-Saharan African ... higher the country,s incidence of TB. The research concluded that ... cases annually may be attributable to mining. "We ...
... the U.S. Army Medical Research and Materiel Command,s 2010 ... Aug. 16-19, St. Pete Beach, Florida. The ATACCC ... focus on the battlefield medical needs of our Nation,s ... medicine. The conference generates intense discussion, focused meetings, and ...
... ). To the surprise of researchers at Mayo Clinic ... that provides benefit to patients with metastatic colon cancer ... III cancer. In fact, patients who used the agent, ... treated with chemotherapy alone. The phase III North ...
... CHICAGOA therapy that multiplies the effect of a natural ... metastatic melanoma in a large, international clinical trial. The ... American Society of Clinical Oncology (ASCO) annual meeting in ... Medicine . Patients in the phase III clinical ...
Cached Medicine News:Health News:The John Theurer Cancer Center recognizes medical physics team for safety track record 2Health News:Study: Mining is a major driver of sub-Saharan Africa's TB epidemic 2Health News:Drug that helps metastatic colon cancer of no benefit in less advanced tumors 2Health News:Drug that helps metastatic colon cancer of no benefit in less advanced tumors 3Health News:Antibody therapy lengthens survival of metastatic melanoma patients in large clinical trial 2Health News:Antibody therapy lengthens survival of metastatic melanoma patients in large clinical trial 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: